Medical Condition News

RSS

BioLineRx's BL-1020 Phase IIb EAGLE trial data on schizophrenia to be presented at ECSR

BioLineRx, a biopharmaceutical development company, today announced that data from the successfully completed Phase IIb EAGLE study of BL-1020, a first in class GABA-enhanced antipsychotic for the treatment of schizophrenia, will be presented at the 3rd European Conference on Schizophrenia Research (ECSR) held in Berlin, Germany.

28 Sep 2011

Scientists identify proteasome phosphatase that appears to regulate removal of damaged proteins

A study by scientists at the University of California, San Diego and UC Irvine has identified an enzyme called a proteasome phosphatase that appears to regulate removal of damaged proteins from a cell. The understanding of how this process works could have important implications for numerous diseases, including cancer and Parkinson's disease.

28 Sep 2011

Highly prevalent urinary and bladder symptoms will increase further

Nearly half of all adults over 20 will experience at least one lower urinary tract symptom by 2018 - an estimated 2.3 billion people and a worldwide increase of 18% in just one decade - according to research in the October issue of the urology journal BJUI.

28 Sep 2011

Asthmatic kids with type 1 diabetes have tougher time maintaining healthy sugar levels: Study

The reason why asthma might complicate pediatric diabetes care remains unclear, however, and is “something that needs to be explored more,” said Dr. Anita Swamy, a pediatric endocrinologist and medical director of the Chicago Children's Diabetes Center at La Rabida Children's Hospital in Chicago. She was not involved in the new study. The study appears in the October issue of Pediatrics.

27 Sep 2011

Low vitamin B12 raises risk of dementia in the elderly: Study

According to a latest study the elderly with low levels of vitamin B12 in their blood may be more likely to develop problems with their thinking skills and have more brain shrinkage. The study points to a link between low B12 and early cognitive decline, a condition that often leads to dementia. Previous research has found that those people with high levels of vitamin B12 in their blood have lower levels of an amino acid called homocysteine, which some studies have linked to an increased risk of Alzheimer's disease, memory loss, and stroke.

27 Sep 2011

Raised blood pressure may higher risk of cancer, death

Raised blood pressure is linked to a higher risk of developing cancer or dying from the disease according to the findings of the largest study to date to investigate the association between the two conditions.

27 Sep 2011

$Hip fracture may increase short-term mortality for women ages 65 to 79 years$

Hip fracture may increase short-term mortality for women ages 65 to 79 years

Hip fracture is associated with an increase in short-term mortality (death within one year) for women ages 65 to 79 years and healthy women ages 80 years and older, although the risk returns to previous levels after one year for women ages 70 years and older, according to a report published Online First by Archives of Internal Medicine, one of the JAMA/Archives journals.

27 Sep 2011

22nd Century completes enrollment in X-22 Phase II-B smoking cessation study

22nd Century Group, Inc., a company focused on smoking cessation and tobacco harm reduction products, announced today that enrollment of its X-22 Phase II-B clinical trial has been successfully completed; 234 smokers have been randomized in the double-blind, active-controlled, multi-center smoking cessation study.

27 Sep 2011

NYU Langone to lead NVVLS on long-term effects of PTSD

NYU Langone Medical Center announced that Charles R. Marmar, MD, the Lucius N. Littauer Professor of Psychiatry and chair of the Department of Psychiatry, was selected to lead the clinical evaluation component of a national survey — the National Vietnam Veterans Longitudinal Study (NVVLS) — on the long-term effects of combat-related post-traumatic stress disorder (PTSD) and other related health conditions on Vietnam veterans.

27 Sep 2011

Two computerized tests increase ability to detect remaining vision in patients with RP

Two new computerized tests increase the ability to measure remaining vision in patients with retinitis pigmentosa (RP) and other blinding diseases, reports a study in the October issue of Optometry Vision Science, official journal of the American Academy of Optometry.

27 Sep 2011

WPI professor receives AHA fellowship for research into cardiovascular disease

Dalin Tang, professor of mathematical sciences and biomedical engineering at Worcester Polytechnic Institute (WPI), has been elected a fellow of the American Heart Association (AHA). Tang was elected to fellowship by the AHA's Council on Basic Cardiovascular Sciences in recognition of his "major and productive contributions in cardiovascular basic science."

27 Sep 2011

Double balloon enteroscopy safe and effective for detection of small intestine diseases

A large-scale data review by researchers in China of double balloon enteroscopy (DBE) over the last decade showed the endoscopic procedure to be safe and effective for detection of diseases of the small intestine.

27 Sep 2011

Close link between SF3B1 mutation and specific feature of myelodysplastic syndromes

Geneticists have discovered that a gene involved in the modification of ribonucleic acid (RNA) is mutated in a significant proportion of people with a collection of blood cancers called myelodysplastic syndromes.

27 Sep 2011

HCRI completes enrollment in dual antiplatelet therapy clinical trial

The Harvard Clinical Research Institute (HCRI) announced today that the enrollment phase of the DAPT Study has been successfully completed. The DAPT Study is a four-year clinical trial investigating the duration of dual antiplatelet therapy (DAPT, the combination of aspirin and a thienopyridine/antiplatelet medication to reduce the risk of blood clots) following drug-eluting stent implantations.

27 Sep 2011

Afraxis to participate in NIH's Therapeutics for Rare and Neglected Disease Program

Afraxis, a San Diego-based biotechnology company developing drugs to treat rare genetic diseases through the modulation of p21-activated kinase (PAK), announced today that it has been selected to participate in the National Institutes of Health's (NIH) Therapeutics for Rare and Neglected Disease (TRND) Program.

27 Sep 2011

Subtle and unspoken clues exchanged by patients, doctors exert an influence on medical care

Subtle and unspoken clues exchanged by patients and doctors exert an influence on medical care, according to a new study by the University of Michigan Health System. Researchers analyzed video recordings of routine checkups and conducted follow-up interviews with participants to help elucidate signals sent and received on both sides of the examination table.

27 Sep 2011

Patients with chronic conditions likely to change their preferences for CPR

Patients with chronic conditions are likely to change their preferences for receiving emergency procedures in the event of cardiac arrest, according to new findings.

27 Sep 2011

New Banner MD Anderson center to deliver unprecedented cancer care in Arizona

Banner MD Anderson Cancer Center, a unique collaboration between Banner Health and The University of Texas MD Anderson Cancer Center, opens today, ushering in a new era of unprecedented cancer care in Arizona.

27 Sep 2011

Arena, Eisai announce new data from lorcaserin Phase 3 clinical trial program

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that new data analyses from the lorcaserin Phase 3 clinical trial program will be presented in poster sessions at Obesity 2011, the 29th Annual Scientific Meeting of The Obesity Society in Orlando, Florida.

27 Sep 2011

Elevation presents positive data from EP-101 Phase 2a study on COPD at ERS annual meeting

Elevation Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of new aerosol therapies for patients with respiratory diseases, announced today that it presented positive results from a Phase 2a study of EP-101 in patients with moderate to severe chronic obstructive pulmonary disease (COPD), a large and growing disease characterized by significant unmet clinical needs, at the annual meeting of the European Respiratory Society.

27 Sep 2011

Medical Condition News

BioLineRx's BL-1020 Phase IIb EAGLE trial data on schizophrenia to be presented at ECSR

Scientists identify proteasome phosphatase that appears to regulate removal of damaged proteins

Highly prevalent urinary and bladder symptoms will increase further

Asthmatic kids with type 1 diabetes have tougher time maintaining healthy sugar levels: Study

Low vitamin B12 raises risk of dementia in the elderly: Study

Raised blood pressure may higher risk of cancer, death

Hip fracture may increase short-term mortality for women ages 65 to 79 years

22nd Century completes enrollment in X-22 Phase II-B smoking cessation study

NYU Langone to lead NVVLS on long-term effects of PTSD

Two computerized tests increase ability to detect remaining vision in patients with RP

WPI professor receives AHA fellowship for research into cardiovascular disease

Double balloon enteroscopy safe and effective for detection of small intestine diseases

Close link between SF3B1 mutation and specific feature of myelodysplastic syndromes

HCRI completes enrollment in dual antiplatelet therapy clinical trial

Afraxis to participate in NIH's Therapeutics for Rare and Neglected Disease Program

Subtle and unspoken clues exchanged by patients, doctors exert an influence on medical care

Patients with chronic conditions likely to change their preferences for CPR

New Banner MD Anderson center to deliver unprecedented cancer care in Arizona

Arena, Eisai announce new data from lorcaserin Phase 3 clinical trial program

Elevation presents positive data from EP-101 Phase 2a study on COPD at ERS annual meeting

Microphysiological systems in drug discovery

Considerations for taking ASO discovery programs into animal models

Neurofilament light as a translational biomarker

Latest News